1,1'-Carbonyldiimidazole → (3R,5S)-1-((S)-4-(N-(but-3-enyl)-2-nitrophenylsulfonamido)-2-(tert-butoxycarbonylamino) butanoyl)-5-((1R,2S)-1-(ethoxycarbonyl)-2-vinylcyclopropylcarbamoyl)pyrrolidin-3-yl 4-fluoroisoindoline-2-carboxylate

HRID 1171964

반응식

HRID 1171964 반응식
[CH2:1]([N:5]([CH2:18][CH2:19][C@H:20]([NH:42][C:43]([O:45][C:46]([CH3:49])([CH3:48])[CH3:47])=[O:44])[C:21]([N:23]1[CH2:27][C@H:26]([OH:28])[CH2:25][C@H:24]1[C:29]([NH:31][C@:32]1([C:37]([O:39][CH2:40][CH3:41])=[O:38])[CH2:34][C@H:33]1[CH:35]=[CH2:36])=[O:30])=[O:22])[S:6]([C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][C:10]=1[N+:15]([O-:17])=[O:16])(=[O:8])=[O:7])[CH2:2][CH:3]=[CH2:4].N1([C:55]([N:57]2[CH:61]=[CH:60]N=[CH:58]2)=[O:56])C=CN=C1.C(N(C(C)C)C(C)C)C.Cl.[F:72][C:73]1C=[CH:80][CH:79]=[C:78]2[C:74]=1CNC2>C1(C)C=CC=CC=1>[F:72][C:73]1[CH:74]=[CH:78][CH:79]=[C:80]2[C:60]=1[CH2:61][N:57]([C:55]([O:28][C@@H:26]1[CH2:25][C@@H:24]([C:29](=[O:30])[NH:31][C@:32]3([C:37]([O:39][CH2:40][CH3:41])=[O:38])[CH2:34][C@H:33]3[CH:35]=[CH2:36])[N:23]([C:21](=[O:22])[C@@H:20]([NH:42][C:43]([O:45][C:46]([CH3:48])([CH3:47])[CH3:49])=[O:44])[CH2:19][CH2:18][N:5]([CH2:1][CH2:2][CH:3]=[CH2:4])[S:6]([C:9]3[CH:14]=[CH:13][CH:12]=[CH:11][C:10]=3[N+:15]([O-:17])=[O:16])(=[O:8])=[O:7])[CH2:27]1)=[O:56])[CH2:58]2

참가 물질

6

반응물 4

HCID 682631,1'-CarbonyldiimidazoleHCID 81531DiisopropylethylamineHCID 426096434-Fluoro-1H-isoindoline hydrochlorideHCID 59554237(1R,2S)-ethyl 1-((2S,4R)-1-((S)-4-(N-(but-3-enyl)-2-nitrophenylsulfonamido)-2-(tert-butoxycarbonylamino)butanoyl)-4-hydroxypyrrolidine-2-carboxamido)-2-vinylcyclopropanecarboxylate

생성물 1

HCID 59554077(3R,5S)-1-((S)-4-(N-(but-3-enyl)-2-nitrophenylsulfonamido)-2-(tert-butoxycarbonylamino) butanoyl)-5-((1R,2S)-1-(ethoxycarbonyl)-2-vinylcyclopropylcarbamoyl)pyrrolidin-3-yl 4-fluoroisoindoline-2-carboxylate수율 84%

시약·촉매·용매 1

HCID 1140Toluene용매

실험 절차

(1R,2S)-ethyl 1-((2S,4R)-1-((S)-4-(N-(but-3-enyl)-2-nitrophenylsulfonamido)-2-(tert-butoxycarbonylamino)butanoyl)-4-hydroxypyrrolidine-2-carboxamido)-2-vinylcyclopropanecarboxylate (1.60 g, 2.26 mmol) in toluene (20 mL) was added di(1H-imidazol-1-yl)methanone (0.48 g, 2.94 mmol) in one portion. The reaction was stirred at rt for 3 hrs. To the reaction was then added the N-ethyl-N-isopropylpropan-2-amine (1.97 ml, 11.30 mmol), followed by 4-Fluoroisoindoline hydrochloride (1.27 g, 4.52 mmol). The reaction was stirred at 60° C. for 3 hrs. The solvent was removed. The residue was partitioned between ethyl acetate (30 mL) and saturated sodium bicarbonate solution. The organic layer was separated and dried over sodium sulfate. After removal of solvent, the residue was purified by chromatography (Hexane:Ethyl acetate=1:2) to give (3R,5S)-1-((S)-4-(N-(but-3-enyl)-2-nitrophenylsulfonamido)-2-(tert-butoxycarbonylamino)butanoyl)-5-((1R,2S)-1-(ethoxycarbonyl)-2-vinylcyclopropylcarbamoyl)pyrrolidin-3-yl 4-fluoroisoindoline-2-carboxylate as white solid (1.65 g, 84%). MS: Calcd.: 870; Found: [M+H]+ 871.

후처리

  1. stirringThe reaction was stirred at 60° C. for 3 hrs
  2. customThe solvent was removed
  3. customThe residue was partitioned between ethyl acetate (30 mL) and saturated sodium bicarbonate solution
  4. customThe organic layer was separated
  5. dry with materialdried over sodium sulfate
  6. customAfter removal of solvent
  7. customthe residue was purified by chromatography (Hexane:Ethyl acetate=1:2)

출처 및 근거

ORD 기록
ord-81cb13ee9041467ca41ed5aff498425c
출처 데이터셋
uspto-grants-2010_11
특허 번호
US07829665B2

연결된 노트

불러오는 중…